We discuss the case of a young patient presenting with euglycemic DKA. Say what? How common is this entity and what is the impact of a new class of diabetic medication? We answer these important questions and much more on this episode.
You can get CME credit for this episode here! Click here for CME Account Creation Instructions
Recent trials have produced conflicting results on the benefit of epinephrine in patients with OHCA. PARAMEDIC2 was just published and is the largest randomized...
In this podcast we discuss the very controversial SSC 2018 Update. We know that sepsis is a time-sensitive illness, but does a 1-hour bundle...
Bryan Hayes rejoins the podcast to discuss some great pearls and pitfalls with select medications used to resuscitate and treat critically ill patients. This...